$ABBV 3 SEC Filings

Filed On	Filing
23 Oct 2026	Form 3: Carethers John, Director No securities owned
11 Jul 2025	Form 3: AbbVie Inc., EVP, Chief HR Officer Holds 7,048 shares of Common stock, $0.01 par value
13 May 2025	Form 3: Falk Thomas J, Director Holds 1,203 shares of Common Stock, $0.01 par value
10 Mar 2025	Form 3: Purdue David Ryan, SVP, Controller Holds 4,505 shares of Common Stock, $0.01 par value
22 Dec 2023	Form 3: Thakkar Roopal, SVP, Global Therapeutics & CMO Holds 30,225 shares of Common Stock, $0.01 par value
19 Oct 2023	Form 3: Davis Jennifer L., Director No securities owned
19 Oct 2023	Form 3: Quaggin Susan E, Director No securities owned
10 Jul 2023	Form 3: Donoghoe Nicholas, EVP, Chief Bus/Strat Officer Holds 58,815 shares of Common Stock, $0.01 par value
10 Mar 2023	Form 3: Buckbee Kevin K, SVP, Controller Holds 7,163 shares of Common Stock, $0.01 par value
27 Oct 2022	Form 3: Siatis Perry C, EVP, GC and Secretary Holds 10,377 shares of Common Stock, $0.01 par value
08 Jul 2022	Form 3: Reents Scott T, SVP, Chief Financial Officer Holds 809 shares of Common Stock, $0.01 par value
19 Nov 2020	Form 3: Sorg Elaine K., Sr. V.P., U.S. Commercial Ops. Holds 17,595 shares of Common Stock, $0.01 par value
12 May 2020	Form 3: Strom Carrie C, SVP & Pres Global Allerg Aesth Holds 0 shares of Common Stock, $0.01 par value
12 May 2020	Form 3: Freyman Thomas C, Director Holds 114,759 shares of Common Stock, $0.01 par value
09 Jul 2019	Form 3: Hudson Thomas J, SVP, R&D and CSO Holds 12,748 shares of Common stock, $0.01 par value
04 Jan 2019	Form 3: Donoghoe Nicholas, SVP, Enterprise Innovation Holds 0 shares of Common stock, $0.01 par value
12 Dec 2018	Form 3: Stewart Jeffrey Ryan, SVP, US Commercial Operations Holds 29,478 shares of Common stock, $0.01 par value
24 Oct 2018	Form 3: Durkin Brian L, VP, Controller Holds 4,251 shares of Common stock, $0.01 par value
07 May 2018	Form 3: Roberts Rebecca B, Director Holds 0 shares of Common stock, $0.01 par value
09 May 2017	Form 3: Meyer Melody B, Director Holds 0 shares of Common stock, $0.01 par value

Comments